1. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing;Mancuso;Lancet,2021
2. Hemophilia A: strategies for improving long-term holistic management, adherence, and quality of life;Escobar;J Adv Pract Oncol,2022
3. Extended half-life coagulation factors: a new era in the management of hemophilia patients;Ar;Turk J Haematol,2019
4. Efanesoctocog alfa prophylaxis for patients with severe hemophilia A;von Drygalski;N Engl J Med,2023
5. Factor VIII replacement is still the standard of care in haemophilia A;Aledort;Blood Transfus,2019